Bachem Holding AG
Open
SectorHealthcare
77.95 -1.89
Overview
Share price change
24h
Min
77.8
Max
80.84
Income | -48M 50M |
|---|---|
Sales | -56M 326M |
P/E Sector Avg | 38.864 56.597 |
EPS | 1.317 |
Dividend yield | 1.17 |
Profit margin | 15.399 |
Employees | 2,725 |
EBITDA | -25M 82M |
Dividend yield Sector Avg | 1.17% 2.18% |
|---|
Market Cap | 326M 5.8B |
|---|---|
Previous open | 79.84 |
Previous close | 77.95 |
News Sentiment
By Acuity
100%
0%
322 / 339 Healthcare
Bachem Holding AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Bachem Holding AG Forecast
Sentiment
By Acuity
322 / 339 Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Bachem Holding AG
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.